In a report released on February 1, Casey Woodring from J.P. Morgan maintained a Hold rating on Charles River Labs (CRL – Research Report), ...

Read here for an analysis of Charles River's (CRL) strong financial performance with high ROE and decreasing liabilities, indicating future capital deployment.

While refusing to quash an FIR under Section 376 IPC for false promise of marriage, the Delhi High Court observed that the ...

LOS ANGELES, CA / ACCESS Newswire / February 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...

Flagship Harbor Advisors LLC purchased a new stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) ...

Fifth Third Bancorp cut its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by ...

Be it noted, the Bench then notes in para 14 that, “Importantly, it must be noted that the case as of now, after the filing of chargesheet, survives only to the extent of allegations under Sections ...

Shares of Charles River Laboratories International Inc. CRL shed 1.22% to $161.64 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX ...

CNS-focused biopharma Axsome Therapeutics has won US Food and Drug Administration (FDA) approval for Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in ...

Sage’s board of directors said that the proposal “significantly undervalues” the company and is not in the best interest of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of Charles River Laboratories International Inc. CRL slipped 1.33% to $163.64 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index ...